NCT07832643 Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age
| NCT ID | NCT07832643 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Allergy |
| Study Type | INTERVENTIONAL |
| Enrollment | 508 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 508 participants in total. It began in 2026-07-01 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The number of people with allergies has been steadily increasing over the years. Symptoms in infants, such as bronchiolitis, gastroesophageal reflux, eczema, or atopic dermatitis, can be early warning signs of allergies in childhood. Given the rising prevalence of allergies and the number of children affected by bronchiolitis, it is worth investigating whether the presence of allergies in parents is associated with a higher likelihood of developing bronchiolitis in childhood. To determine the incidence of respiratory distress in infants with at least one allergic parent compared to infants with no allergic parents at 12 months of age. Parents will be asked to complete a questionnaire at two time points: at 6 months and at 12 months of age. The incidence of bronchiolitis during the first year of life is higher among infants with at least one parent who has allergies.
Eligibility Criteria
Inclusion Criteria: * Newborns delivered at Amiens Picardie University Hospital, Full-term newborns, i.e., * ≥ 37+0 weeks of gestation (SA), * Newborns whose mothers are of legal age and capable of understanding, reading, and speaking French or, failing that, who have someone in their immediate circle capable of understanding, reading, and speaking French; * Newborns whose mothers are enrolled in the social security system; Exclusion Criteria: * Premature newborns * Newborns whose parents refused to allow them to participate in the study * Newborns from multiple pregnancies * Newborns with malformations diagnosed prenatally or immediately after birth (in the delivery room)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07832643 clinical trial?
This trial is open to participants of all sexes, up to 1 Year, studying Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07832643 currently recruiting?
Yes, NCT07832643 is actively recruiting participants. Contact the research team at tourneux.pierre@chu-amiens.fr for enrollment information.
Where is the NCT07832643 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT07832643 clinical trial?
NCT07832643 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 508 participants.